Companies / California / Alto Neuroscience

· rebuilt nightly from public records

Signal Sheet

Selling to Alto Neuroscience? Who to reach and why now

Alto Neuroscience is a listed pharmaceuticals company in Mountain View, California. It raised $50M in Oct 2025, has 10 open roles and its filings name 9 officers. Everything below links to the record it came from.

Listed company · Pharmaceuticals · California

For sellersWhy Alto Neuroscience is worth a call this quarterBuy Window: watching
10Nov 2026

Building a team

Open roles on the company's own careers page, read nightly.

Hiring
$50M

New budget

Equity raise reported to the SEC, Oct 2025.

Capital
Track Alto Neuroscience with a free trial →Get the next signal the day it is filed or posted.
Sell to companies like this?

Select your targets, see why-now for every account

Pick the companies and territory you sell to and get dated, sourced reasons like these for each one, ranked by who is most likely to buy now. Your list stays yours.

Want this matched to what you sell? Get early access to Pursuit Plans →
Start your free trial →

Why now

The most recent events first, refreshed every night. Each links to the record it came from.

WhenWhat happenedKindSource
Nov 10, 202610 open rolesHiringCareers page
Oct 21, 2025Raised $50M in equity from 7 investorsCapitalSEC filing

Who to reach

The roles that matter for a seller right now. Names on this page come from SEC filings or the company's own announcements. Contacts you find with a free trial are verified before you see them. How we source names

RoleContactSourceWhy they matter now
Executive OfficerAmit EtkinSEC filing, Oct 2025Named officer in the filing; part of the buying group
Executive OfficerMichael HanleySEC filing, Oct 2025Named officer in the filing; part of the buying group
Executive OfficerAdam SavitzSEC filing, Oct 2025Named officer in the filing; part of the buying group
Executive OfficerNicholas C. SmithSEC filing, Oct 2025Named officer in the filing; part of the buying group
Chief Technology OfficerGwill YorkSEC filing, Oct 2025Technology and tooling decisions
Chief Technology OfficerChristopher Nixon CoxSEC filing, Oct 2025Technology and tooling decisions
Chief Technology OfficerAndrew DreyfusSEC filing, Oct 2025Technology and tooling decisions
Chief Technology OfficerHusseini ManjiSEC filing, Oct 2025Technology and tooling decisions
Chief Technology OfficerRaymond SanchezSEC filing, Oct 2025Technology and tooling decisions
Showing 3 of 9Start a free trial to see all 9 →

Turn this page into pipeline

Lakewave does the research, the stitching and the first draft with AI, so you spend your time selling.

Lead Hunting

Watch Alto Neuroscience for the next signal

Lakewave tracks raises, new leaders, hiring and filings across your accounts and territory, and tells you the day something changes.

Surge and Campaigns

Reach the right people, verified

Find the decision makers, get mailbox-verified addresses and an AI draft written for that account, which you review. Send from your own inbox with open and reply tracking and a follow-up sequence.

Pursuit Plans, early access

A plan built around what you sell

Which accounts to pursue, why now, who to reach and what to say, matched to your product and the buyers you sell to.

Turn Alto Neuroscience into pipeline with a free trial →

Emails that land, not bounce

Every address Lakewave gives you is checked against Alto Neuroscience's mail server before you see it. Guessed addresses bounce, and bounces are what push a sender's domain toward the spam folder, so one bad list can cost a rep weeks of deliverability. Lakewave shows how each address was confirmed and leaves out the ones it cannot verify.

Use it two ways. Look up the verified address you need for a call you are already planning. Or let Lakewave do the whole job: find the accounts with a reason to buy now, the right people and their addresses, and draft a first email for each person, so you are not stitching together data sources and research by hand.

Try it on Alto Neuroscience with a free trial →

About Alto Neuroscience

HeadquartersMountain View, California, per the filing address
Industry groupPharmaceuticals
OwnershipListed company
Raise history$50M (Oct 2025)

Similar companies

Private-sector companies in the same industry group and state, ranked by Rising score.

Aeovian Pharmaceuticals · 5Jaguar Health · 3AN2 Therapeutics · 2BlossomHill Therapeutics · 2Kiora Pharmaceuticals · 2Liminatus Pharma · 2See all 6 with a free trial →

Questions people ask

Did Alto Neuroscience raise funding in 2025?

Yes. Alto Neuroscience reported a $50M equity raise to the SEC on Oct 21, 2025 with 7 investors.

Who runs Alto Neuroscience?

The company's SEC filing, Oct 2025 names Amit Etkin (Executive Officer) among its officers.

Is Alto Neuroscience hiring?

Yes. 10 roles were open on its careers page on Nov 10, 2026.

Where is Alto Neuroscience headquartered?

Mountain View, California, per the address on its SEC filing.

Know who is buying before the first callStart your free trial →

Know who is buying before the first call

Select the accounts and territory you sell to and get dated reasons for every company: new budget, new leaders, new hires, with who to reach and a first draft for each contact.

Start your free trial

Rank your targets

Every account you select comes back scored by what changed this month, with the source for each fact.

Verified emails

Named officers from filings and announcements, each with an address verified against the mailbox. No bounces, no guessed patterns, no scraped profiles.

AI-generated first draft

Lakewave writes a first email for each person, tailored to their role and company. You edit, approve and send it from your own mailbox.

Hear about the next one

A weekly note on what changed across your targets, so no account moves without you knowing.

Free trial · No credit card · Built from public records, refreshed nightly

Compiled from public records and refreshed nightly; last updated Nov 10, 2026. Facts are as the SEC, the company's careers page or the company's own announcements published them. Check the source before acting. See something wrong? Tell us and we will correct it.